Skip to main content

Gil Labrucherie

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Gil Labrucherie

Gil Labrucherie is recorded as Board Member at Rezolute, Inc. (RZLT). Gil Labrucherie was last confirmed as CFO at Nektar Therapeutics (NKTR) in a filing dated April 28, 2023. Earlier roles on record: COO and CFO at Nektar Therapeutics (NKTR) until July 1, 2022. Gil Labrucherie has spoken on 7 earnings calls across 1 company, most recently for Nektar Therapeutics on January 11, 2022.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Rezolute, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.